title: Myth: glucagon is an effective first-line therapy for esophageal foreign body impaction.
authors.affiliation: Department of Emergency Medicine, Keck School of Medicine, University of Southern California , Los Angeles, California, United States. sanjayar@usc.edu
authors.forename: Sanjay
authors.initials: S
authors.lastname: Arora
authors.forename: Peter
authors.initials: P
authors.lastname: Galich
mesh_terms: D003679:Deglutition / Q000187:drug effects; D003680:Deglutition Disorders / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology; D004305:Dose-Response Relationship, Drug; D004947:Esophagus; D005547:Foreign Bodies / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy*; D005765:Gastrointestinal Agents / Q000008:administration & dosage*; D005934:Glucagon / Q000008:administration & dosage*; D006801:Humans; D009119:Muscle Contraction / Q000187:drug effects; D009130:Muscle, Smooth / Q000187:drug effects / Q000503:physiopathology; D016896:Treatment Outcome
chemical_list: D005765:Gastrointestinal Agents; D005934:Glucagon